510(k) K222559

BD BACTEC™ Myco/F Lytic Culture Vials by Becton, Dickinson and Company — Product Code MDB

K222559 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "BD BACTEC™ Myco/F Lytic Culture Vials". The FDA issued a decision of Substantially Equivalent on March 24, 2023. The device falls under product code MDB (System, Blood Culturing), a Class I device regulated under 21 CFR 866.2560. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 24, 2023
Date Received
August 24, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Blood Culturing
Device Class
Class I
Regulation Number
866.2560
Review Panel
MI
Submission Type